A REAL WORLD STUDY INVESTIGATING THE RESOURCE USE AND BURDEN ASSOCIATED WITH SPINAL MUSCULAR ATROPHY (SMA) FROM THE PERSPECTIVE OF PATIENTS AND CARERS IN THE UK

被引：0
|
作者：
Rowell, J. [1 ]
Vincent, S. A. [2 ]
Saberian, S. [2 ]
Scoto, M. [3 ]
Muntoni, F. [3 ]
机构：
[1] Roche Prod Ltd, Welwyn Garden City, Hrt, England
[2] OPEN VIE, London, Lon, England
[3] UCL, Dubowitz Neuromuscular Unit, London, England
来源：
VALUE IN HEALTH | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PRO22
引用
收藏
页码：S693 / S693
页数：1
相关论文
共 50 条
  • [1] ASSESSING THE REAL-WORLD HOSPITAL ECONOMIC BURDEN OF SPINAL MUSCULAR ATROPHY (SMA) IN FRANCE
    Tetafort, A.
    Couray-Targe, S.
    Harmand, S.
    Ansolabehere, X.
    Maurel, F.
    Hammes, F.
    VALUE IN HEALTH, 2017, 20 (09) : A553 - A553
  • [2] Health Care Resource Use (HCRU) for patients with spinal muscular atrophy (SMA) Types 2 or 3 in the UK
    Reyna, S.
    Toro, W.
    Patel, A.
    Saleh, S.
    Dabbous, O.
    NEUROMUSCULAR DISORDERS, 2024, 43
  • [3] Burden of Spinal Muscular Atrophy (SMA) on Patients and Caregivers in Canada
    McMillan, H. J.
    Gerber, B.
    Cowling, T.
    Khuu, W.
    Mayer, M.
    Wu, J. W.
    Maturi, B.
    Klein-Panneton, K.
    Cabalteja, C.
    Lochmuller, H.
    JOURNAL OF NEUROMUSCULAR DISEASES, 2021, 8 (04) : 553 - 568
  • [4] Real-world treatment with risdiplam in adults with spinal muscular atrophy (SMA): a multicenter study
    Guittari, C.
    Candrilli, S.
    Miles, L.
    Simpson, A.
    Shapouri, S.
    NEUROMUSCULAR DISORDERS, 2023, 33 : S164 - S164
  • [5] Disease and treatment burden of spinal muscular atrophy (SMA) on patients and caregivers in Canada
    McMillan, H.
    Gerber, B.
    Cowling, T.
    Khuu, W.
    Mayer, M.
    Wu, J.
    Maturi, B.
    Klein-Panneton, K.
    Cabalteja, C.
    Lochmueller, H.
    NEUROMUSCULAR DISORDERS, 2020, 30 : S100 - S101
  • [6] Healthcare Resource Use in Patients with Diagnosis of Spinal Muscular Atrophy (SMA) in OptumT US Claims Database
    Teynor, Megan
    Hou, Qiang
    Zhou, Jia
    Hall, Eric
    Wells, Wendy
    Avendano, Javier
    NEUROLOGY, 2017, 88
  • [7] Real world experience of risdiplam in newborns with spinal muscular atrophy (SMA): a multicenter, retrospective cohort study
    Goedeker, N.
    Dierker, A.
    Felker, M.
    Lakhotia, A.
    Rogers, A.
    Zaidman, C.
    NEUROMUSCULAR DISORDERS, 2023, 33 : S222 - S222
  • [8] Emerging real-world use of nusinersen in adult patients with spinal muscular atrophy (SMA) in the US: A multi-site chart review study
    Paradis, A.
    Cochrane, T.
    Khachatryan, A.
    Martinez, M.
    NEUROMUSCULAR DISORDERS, 2020, 30 : S98 - S98
  • [9] Real-World Patterns of Nusinersen Use in Adult Patients with Spinal Muscular Atrophy (SMA) in the US: A Multi-Site Chart Review Study
    Elman, Lauren
    Youn, Bora
    Proud, Crystal M.
    Frey, Margaret R.
    Ajoud-Driss, Senda
    McCormick, Eileen M.
    Michelson, David
    Cartwright, Michael S.
    Heiman-Patterson, Terry
    Choi, Joseph M.
    Chandak, Aastha
    Khachatryan, Artak
    Martinez, Marta
    Paradis, Angela D.
    NEUROLOGY, 2021, 96 (15)
  • [10] Real-world treatment patterns and outcomes in patients with spinal muscular atrophy (SMA): Updated findings from the RESTORE Registry
    Servais, L.
    Day, J.
    De Vivo, D.
    Mercuri, E.
    Muntoni, F.
    Shieh, P.
    Tizzano, E.
    Desguerre, I.
    Saito, K.
    Menier, M.
    LaMarca, N.
    Anderson, F.
    Dabbous, O.
    Finkel, R.
    NEUROMUSCULAR DISORDERS, 2021, 31 : S138 - S139
12345